期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
连豆清脉方可降低动脉硬化患者臂踝脉搏波速度及其校正指数 被引量:2
1
作者 朱红俊 陆曙 +4 位作者 朱明 苏伟 龚少愚 张志斌 李萍 《时珍国医国药》 CAS CSCD 北大核心 2010年第9期2196-2198,共3页
目的研究有AS危险因素的人群中,臂踝脉搏波速度(baPWV)及其校正指数(baPWVi)和临床事件的相关性,以及连豆清脉方干预AS患者baPWV及baPWVi的效果。方法该研究共计纳入130例研究病例,其中无动脉粥样硬化(AS)相关临床事件患者54例、有AS相... 目的研究有AS危险因素的人群中,臂踝脉搏波速度(baPWV)及其校正指数(baPWVi)和临床事件的相关性,以及连豆清脉方干预AS患者baPWV及baPWVi的效果。方法该研究共计纳入130例研究病例,其中无动脉粥样硬化(AS)相关临床事件患者54例、有AS相关临床事件患者76例,进行baPWV、baPWVi检测;并将其中64例有AS相关临床事件患者,按照随机对照的原则,分为连豆清脉方治疗组和对照组,其中治疗组32例和对照组32例,两组均进行标准治疗,其中治疗组加用连豆清脉方,观察治疗前后baPWV及baPWVi的变化。结果有临床事件组的年龄、baPWV及baP-WVi均明显高于无临床事件组[年龄:(66.7±9.6)岁.vs.(63.3±10.8)岁;baPWV:(20.40±0.67)m/s.vs.(15.72±0.38)m/s;baPWVi:(1.25±0.04).vs.(1.00±0.02),P=0.000)]。Logistic回归分析:baPWVi和临床事件成正相关(r=5.7),具有统计学差异(P=0.028),而baPWV、年龄和临床事件的相关性无统计学差异;baPWVi增高发生临床事件的相对危险度高于baPWV和年龄(OR值:296.6.vs.1.001.vs.0.995)。baPWVi对于临床事件预测的价值高于baPWV和年龄[ROC曲线下面积(AUC):0.808.vs.0.789.vs.0.614)],根据最大约登指数原则,取baPWVi和baPWV的cut-off值(1.043,16.52m/s),预测临床事件的特异性baPWVi高于baPWV(68.5%.vs.62.7%),但是敏感性不如baPWV(76.3%.vs.80.3%)。对照组和连豆清脉方治疗组治疗前的baPWV、baPWVi没有差异,治疗后两组baPWV、baPWVi均下降,但治疗组的下降值明显高于对照组[baPWV:(1.97±0.40)m/s.vs.(0.13±0.17)m/s;baPWVi:(0.12±0.02).vs.(-0.01±0.01),P=0.000)]。结论在有AS危险因素的人群中,baPWVi和临床事件相关性、预测临床事件的能力优于baPWV;连豆清脉方可在标准治疗基础上,进一步降低baPWV及baPWVi。 展开更多
关键词 连豆清脉方 脉搏速度 脉搏速度指数 动脉粥样硬化
下载PDF
中年代谢综合征、糖尿病及糖尿病合并冠心病脉搏波传导速度、踝肱指数对比分析 被引量:3
2
作者 陈民 李玉晓 +1 位作者 李莉 张锐 《中国医药指南》 2012年第10期98-100,共3页
目的对比脉搏波速度(baPWV)、踝臂指数(ABI)在中年代谢综合征(MS)、糖尿病及糖尿病合并冠心病的变化情况从而对中年人及早干预血管,改善预后。方法选择我院体检对象确定为MS的患者204例,分为单纯MS组76例,合并糖尿病MS组54例,糖尿病合... 目的对比脉搏波速度(baPWV)、踝臂指数(ABI)在中年代谢综合征(MS)、糖尿病及糖尿病合并冠心病的变化情况从而对中年人及早干预血管,改善预后。方法选择我院体检对象确定为MS的患者204例,分为单纯MS组76例,合并糖尿病MS组54例,糖尿病合并冠心病MS例74例。采用全自动动脉硬化测定仪测定双侧肱一踝动脉baPWV及踝臂指数(ABI),同时采集动脉硬化相关指标并进行统计学分析。结果本临床研究表明,在单纯MS患者,baPWV显着增高,ABI显着降低(P<0.05);而合并糖尿病的MS患者,baPWV显着高于单纯MS患者,而ABI明显低于单纯MS组(P<0.05);糖尿病合并冠心病组的PWV是三组中最高的,ABI也是三组中最低的。结论聚集多重心血管危险因素的MS患者的baPWV明显增高,ABI明显降低。baPWv增高、ABI降低是评估动脉弹性降低的有效指标。 展开更多
关键词 脉搏传导速度 指数 代谢综合征 糖尿病 冠心病
下载PDF
复方丹参滴丸对下肢动脉疾病早期变化血小板活化分子的影响
3
作者 杨少洁 梁晓萍 鞠鲤亦 《中国中医药咨讯》 2010年第16期175-176,共2页
目的:血小板膜糖蛋白在血小板的粘附和聚集等生理过程起关键作用。通过观察复方丹参滴丸对下肢动脉硬化早期变化血小板活化分子的影响,以探讨复方丹参滴丸对下肢动脉硬化早期变化的疗效,尝试单用中药治疗下肢动脉硬化,以降低医药费... 目的:血小板膜糖蛋白在血小板的粘附和聚集等生理过程起关键作用。通过观察复方丹参滴丸对下肢动脉硬化早期变化血小板活化分子的影响,以探讨复方丹参滴丸对下肢动脉硬化早期变化的疗效,尝试单用中药治疗下肢动脉硬化,以降低医药费用。方法:研究对象为年龄大于或等于40周岁下肢动脉硬化早期变化患者45例,服用复方丹参滴丸三个月,治疗前后观察血小板活化分子的变化。下肢动脉硬化诊断方法使用动脉硬化早期测定仪筛检。检测成年人群肱动脉-踝动脉搏波传导速度(brachial—ankle Pulse Wave Velocity,baPWV)和踝臂指数(brachial—ankle index,ABI),了解血管弹性状况。利用FCM检测外周血小板的膜糖蛋白CD62p、CD63、CD41、CD61的表达并在治疗前后进行对比。结果:在参于体检的525人中,baPWV检测值轻度升高者占13%;中度升高者占22%;;重度升高者占8%。在baPWV检测值重度升高者中CD62p、CD63表达均显著高于正常组(P〈0.01)。服用复方丹参滴丸治疗三个月后CD62p、CD63表达均显著低于治疗前(P〈0.01)。结论:复方丹参滴丸可以降低血小板的活化状态。故服用复方丹参滴丸对心脑血管事件的一级和二级预防有重要意义。 展开更多
关键词 复方丹参滴丸 肱动脉-脉搏传导速度和指数 血小板的活化状态
下载PDF
Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population 被引量:5
4
作者 Xin-yan YU Yi ZHAO +1 位作者 Xiao-xiao SONG Zhen-ya SONG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2014年第10期879-887,共9页
Background and objective: Non-alcoholic fatty liver disease(NAFLD) is associated with arterial stiffness in the general population. Age, obesity, hypertension, and diabetics are risk factors for arterial stiffness.... Background and objective: Non-alcoholic fatty liver disease(NAFLD) is associated with arterial stiffness in the general population. Age, obesity, hypertension, and diabetics are risk factors for arterial stiffness. In this study, we aimed to investigate the association between NAFLD and arterial stiffness as measured by brachial-ankle pulse wave velocity(baPWV) in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population. Methods: A cross-sectional study with 1296 non-obese, non-hypertensive, and non-diabetic young and middle-aged(20–65 years) subjects undergoing routine medical check-ups in the International Health Care Center of the Second Affiliated Hospital of School of Medicine of Zhejiang University was carried out. Fatty liver was diagnosed by ultrasonography, and baPWV was measured using an automatic waveform analyzer. The subjects were classified into two groups according to the presence of NAFLD, and divided into a further two groups according to their baPWV. Results: The overall incidence of NAFLD was 19.0%, and NAFLD patients had a significantly higher level of baPWV than the controls((1321±158) cm/s vs.(1244±154) cm/s; P〈0.001). The incidence of NAFLD was clearly higher in the increased baPWV group than in the normal baPWV group(29.3% vs. 16.9%; P〈0.001), and the incidence increased in line with the increase of baPWV quartiles in the normal range as well as with the severity of arterial stiffness(both P for trend 〈0.001). Multiple linear logistic regression analysis showed that the presence of NAFLD was positively and independently associated with baPWV. Conclusions: Our results suggest that the presence of NAFLD is associated with arterial stiffness as measured by baPWV in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population. 展开更多
关键词 Non-alcoholic fatty liver disease Arterial stiffness Brachial-ankle pulse wave velocity Risk factor
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部